Skip to main content
Top

Journal of Bone and Mineral Metabolism

Issue 3/1998

Content (9 Articles)

Special report

Diagnostic criteria of primary osteoporosis

Hajime Orimo, Youichi Sugioka, Masao Fukunaga, Yoshiteru Muto, Takao Hotokebuchi, Itsuo Gorai, Tetsuro Nakamura, Kazuhiro Kushida, Hiroyuki Tanaka, Tetsuo Ikai, Yasuo Oh-hashi

Original articles

Requirement of osteoblastic cells for the fusion of preosteoclasts

Masamichi Takami, Je-Tae Woo, Kazuo Nagai

Effect of Staphylococcus aureus extracellular proteinaceous fraction in an isolated osteoclastic resorption assay

M. Arora, N. Shah, S. Meghji, B. Henderson, M. Harris, S. Nair, M. Wilson, C. M. Gray, S. J. Jones, A. Boyde

Estimation of the effects of prednisolone on bone metabolism in rats by biochemical markers

Shintaro Koyama, Kazuhiro Kushida, Masaaki Takahashi, Kouichi Kawana, Hironobu Hoshino, Chiaki Ishihara, Tetsuo Inoue

The role of hepatocyte growth factor in growth plate cartilage

Akitoshi Jikko, Kazuo Yamashita, Masahiro Iwamoto, Hiroko Hiranuma, Toshiaki Takebayashi, Takashi Maeda, Mamoru Sakuda, Kunio Matsumoto, Toshikazu Nakamura, Motomi Enomoto-Iwamoto, Makoto J. Tabata, Hajime Fuchihata, Kojiro Kurisu

Calcium supplementation and parathyroid hormone

Shigeki Ohgitani, Yoshio Fujii, Takuo Fujita

Newborn bone mineral density and health care during pregnancy

Yan Lin Wang, Hanwen Wu, Yi bin Liu, Jacques LeBlanc

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.